Patents by Inventor Liankun Gu

Liankun Gu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Methods and nucleotide fragments of predicting occurrence, metastasis of cancers and patients' postoperative survival in vitro

Patent number: 10214778

Abstract: Provided in the present invention are a method using in vitro measurement of the content of methylation or demethylation of GFRa1 CpG islands to estimate a risk of tumorigenesis and of tumor metastasis, or postoperative life expectancy, and a nucleotide sequence used.

Type: Grant

Filed: February 21, 2017

Date of Patent: February 26, 2019

Assignee: Beijing Institute For Cancer Research

Inventors: Dajun Deng, Jun Zhang, Zhaojun Liu, Jing Zhou, Liankun Gu, Baozhen Zhang
METHODS AND NUCLEOTIDE FRAGMENTS OF PREDICTING OCCURRENCE, METASTASIS OF CANCERS AND PATIENTS' POSTOPERATIVE SURVIVAL IN VITRO

Publication number: 20170204471

Abstract: Provided in the present invention are a method using in vitro measurement of the content of methylation or demethylation of GFRa1 CpG islands to estimate a risk of tumorigenesis and of tumor metastasis, or postoperative life expectancy, and a nucleotide sequence used.

Type: Application

Filed: February 21, 2017

Publication date: July 20, 2017

Inventors: Dajun Deng, Jun Zhang, Zhaojun Liu, Jing Zhou, Liankun Gu, Baozhen Zhang
Methods and nucleotide fragments of predicting occurrence, metastasis of cancers and patients' postoperative survival in vitro

Patent number: 9637797

Abstract: Provided in the present invention are a method using in vitro measurement of the content of methylation or demethylation of GFRa1 CpG islands to estimate a risk of tumorigenesis and of tumor metastasis, or postoperative life expectancy, and a nucleotide sequence used.

Type: Grant

Filed: February 13, 2012

Date of Patent: May 2, 2017

Assignee: Beijing Institute For Cancer Research

Inventors: Dajun Deng, Jun Zhang, Zhaojun Liu, Jing Zhou, Liankun Gu, Baozhen Zhang
METHODS AND NUCLEOTIDE FRAGMENTS OF PREDICTING OCCURRENCE, METASTASIS OF CANCERS AND PATIENTS' POSTOPERATIVE SURVIVAL IN VITRO

Publication number: 20160040243

Abstract: Provided in the present invention are a method using in vitro measurement of the content of methylation or demethylation of GFRal CpG islands to estimate a risk of tumorigenesis and of tumor metastasis, or postoperative life expectancy, and a nucleotide sequence used.

Type: Application

Filed: February 13, 2012

Publication date: February 11, 2016

Applicant: Beijing Institute For Cancer Research

Inventors: Dajun Deng, Jun Zhang, Zhaojun Liu, Jing Zhou, Liankun Gu, Baozhen Zhang

Methods and nucleotide fragments of predicting occurrence, metastasis of cancers and patients' postoperative survival in vitro

METHODS AND NUCLEOTIDE FRAGMENTS OF PREDICTING OCCURRENCE, METASTASIS OF CANCERS AND PATIENTS' POSTOPERATIVE SURVIVAL IN VITRO

Methods and nucleotide fragments of predicting occurrence, metastasis of cancers and patients' postoperative survival in vitro

METHODS AND NUCLEOTIDE FRAGMENTS OF PREDICTING OCCURRENCE, METASTASIS OF CANCERS AND PATIENTS' POSTOPERATIVE SURVIVAL IN VITRO